chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Had a CT chest which revealed pleural effusion, and pericardial effusion.; Had a CT chest which revealed pleural effusion, and pericardial effusion.; I started having left-sided chest pains.; chills; night sweats; I had an increase in joint pains.; This is a spontaneous report from a contactable consumer reported herself. A 50-year-old female patient received first dose of BNT162B2 (Pfizer-Biontech Covid-19, Solution for Injection, Lot number: ELO140), via an intramuscular route on left arm 21Dec2020 at 13:00, as a single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. the patient does not have any medical illness. No known allergies have been reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not receive any other medications within 2 weeks of vaccination. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has been tested for COVID-19. On an unknown date, during the month of December, after taking the first covid shot, patient experienced an increase in joint pains which continued throughout the month of January. In Feb2021, she started having chills at sundown with night sweats. But no fever, no cough. On 28May2021 at 15:00, she started having left-sided chest pains. No cough, no fever, no chills. On 03Jun2021, patient went to the emergency room at work and had a CT chest which revealed pleural effusion, and pericardial effusion. Adverse events resulted in Doctor or other healthcare professional office/clinic visit. Therapeutic measures taken as a result of the events included admission to emergency room/department or urgent care for 3 days and received IV Doxycycline, IV Rocephin, Toradol, Losartan, Pepcid and Colchine. On an unknown date, patient received second dose of BNT162B2 (Pfizer-Biontech Covid-19, Solution for Injection, Lot number: EL 3302) on the left arm as a single dose for covid-19 immunization. The patient underwent lab test and procedure which included post vaccination covid tests, nasal swab rapid test on 03Jun2021, test result: negative and covid PCR test on 04Jun2021, test result: negative. The clinical outcome of the events was recovered on an unknown date.  Information on batch/lot numbers are available. Further information has been requested.; Sender's Comments: Based on the information available and temporal association, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported events. The case will be reassessed once new information is available  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
tinnitus; vertigo; balance problems; brain fog; listlessness; extreme fatigue; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received second dose bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: UNKNOWN), dose 2 via an unspecified route of administration on 18Mar2021 as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: EN6198), via an unspecified route of administration for Covid-19 immunisation. On 18Mar2021 patient received second dose of Pfizer vaccine and suffered with severe tinnitus, vertigo, balance problems, brain fog, listlessness, and extreme fatigue on an unspecified date. It has been 19 weeks with little relief. The outcome events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Started with one big rash patch cicle At the arm of the vaccine,  one week after torso full of rash looking like pityriasis rosea
Flu like symptoms for 4 days following, abnormally sore upper arm for 8 days following, and a red itchy rash on the upper arm for 7 days following
Shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced HERPES ZOSTER (Shingles). At the time of the report, HERPES ZOSTER (Shingles) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  Treatment included unknown antivirals.
MMR and DTP given in L thigh on 6/23 at Pre-Kdg checkup. Pt developed fever to 102 on 3/24 and awoke 6/25 am with markedly swollen, warm and red area covering the entire L thigh.
Pain and soreness started the day of injection. 5 days after injection,  left arm started swelling (4 inches by 3.5 inches), warm to touch, and pain.
PATIENT STATED THAT SHE HAD A HISTAMINE REACTION. WARM FEELING THROUGH WHOLE BODY, TURNED RED AND FLUSHED, SORE THROAT, AND CONGESTION. PATIENT TOOK BENADRYL WHICH HELPED RESOLVE ISSUES.
5 cold sores on bottom lip; Breaking out in neck area; This spontaneous case was reported by a consumer and describes the occurrence of ORAL HERPES (5 cold sores on bottom lip) and RASH (Breaking out in neck area) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ORAL HERPES (5 cold sores on bottom lip) and RASH (Breaking out in neck area). At the time of the report, ORAL HERPES (5 cold sores on bottom lip) and RASH (Breaking out in neck area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient received Covid vaccine on 20feb2021. Patient is breaking out in neck area, 5 cold sores on bottom lip.
rash, itchy and red in her back; rash, itchy and red in her back; rash, itchy and red in her back .; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (rash, itchy and red in her back), ERYTHEMA (rash, itchy and red in her back) and RASH (rash, itchy and red in her back .) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (rash, itchy and red in her back), ERYTHEMA (rash, itchy and red in her back) and RASH (rash, itchy and red in her back .). At the time of the report, PRURITUS (rash, itchy and red in her back), ERYTHEMA (rash, itchy and red in her back) and RASH (rash, itchy and red in her back .) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Extremely sore arm, difficult to raise above my head. Lump in armpit making that area extremely sore [this is of concern as I am a breast cancer survivor] Pounding headache Overall achy body Nausea, no vomiting
Pt's arm hurt a bit for a couple days, then the pain "subsided" for a couple days, then all of a sudden, about 4 days later (around the 9th) the pain was so severe that it woke her up at night & has hurt a lot since (it's been about a week). The pt has been babying her arm & can hardly move it. The pain is at the injection site.
swelling and redden 4x3 inches on (R) shoulder, mild tenderness. No fever on 5/26, from prev. day up to 101.5. No Rx, responed ice, Tylenol
Patient hospitalized 6/21/22 - 6/24/22 with weakness, Covid, renal failure
Swollen arm from shoulder to elbow. Red and warm to the touch. Told patient to see family Dr.
A nurse reported that a 31 month old female received her first injection of Prevnar on 3/3/00. The child was also started on antibiotic therapy for "red ears" the same day that Prevnar was administered. A "couple" of days later, the pt developed hives. As of 3/8/00, the pt's symptoms were worsening.
At 10:30 pt had localized reaction at varicella injection site, within 1 minute of injection. Child complained of itching and had a 1cm papule/hive with itching and redness observed. Hive increased to 1.5cm with no other reactions noted. Ice was applied, 25mg Diphenhydramine HCL, Benadryl PO given. After 45 minutes, hives decreased to less than 1/2cm and no other reaction noted.
Nerve pain in upper back started to increase and had a strange numbing feeling in my neck and face.  Some pain in my abdomen as well.
tiredness; extreme sleepiness could not keep eyes open lasted 1 day; diarreah; followed by sensation of fullness subsiding 4th day; Area a shot mild pain 2 days.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 05Apr2021 09:00 (Lot number: ER8737) at the age of 56 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing); "known allergies : penicillin" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset 05Apr2021, outcome "recovered" (06Apr2021), described as "tiredness"; SOMNOLENCE (non-serious) with onset 05Apr2021, outcome "recovered" (06Apr2021), described as "extreme sleepiness could not keep eyes open lasted 1 day"; DIARRHOEA (non-serious) with onset 05Apr2021, outcome "recovered" (07Apr2021), described as "diarrhea"; ABDOMINAL DISTENSION (non-serious) with onset 05Apr2021, outcome "recovered" (09Apr2021), described as "followed by sensation of fullness subsiding 4th day"; VACCINATION SITE PAIN (non-serious) with onset 05Apr2021, outcome "recovered" (07Apr2021), described as "Area a shot mild pain 2 days.". The events "tiredness", "extreme sleepiness could not keep eyes open lasted 1 day", "diarrhea", "followed by sensation of fullness subsiding 4th day" and "area a shot mild pain 2 days." were evaluated at the physician office visit. Additional information: After first dose patient experienced tiredness, extreme sleepiness could not keep eyes open lasted 1 day. Within 12 hours got diarrhea it lasted 2 days, followed by sensation of fullness subsiding on fourth day. Mild pain in the area of shot for two days. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and not received any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
On 2/1/2021 develop minstroke, with expressive aphasia I was in hospital from 2,1-2/3/2021. 2 weeks after vaccine
Breakthrough case admission after 2 vaccines Moderna 3/22/21 Lot# 002B21A;  Moderna 4/19/21 Lot# 040B21A
COUGH, SOB, CHEST TIGHTNESS, NASAL DRAINAGE, SINUS PRESSURE, GI SYMPTOMS, FATIGUE
Information has been received from a male dentist concerning his female friend who on 08-APR-2008 was vaccinated with VARIVAX (MERCK) instead of ZOSTAVAX (Merck) due to human error.  No adverse effects reported.  The reporting dentist also received VARIVAX (Merck) instead of ZOSTAVAX (Merck) due to human error.  (WAES#:  0804USA04050)  Additional information has been requested.
Third dose of Pfizer administered to 13 year old. Third dose has not been approved for this age range.
Patient experienced chest pain and aches within 12-24 hours after the first dose lasting around 30 minutes. Only experienced chest pains one time. By 09/03 patient was lethargic and had a low grade fever, but did not have any more chest pains.
This spontaneous report was received from a pharmacist refers to a 60 year old female patient. The patient had a concurrent condition of hypertension, hypothyroidism and hypercholesterolemia and codeine allergy. On 07-JUL-2015, the patient was vaccinated with ZOSTAVAX lot # L006382, expiry date 25-MAY-2016, 0.65 ml, subcutaneous in the left deltoid. Concomitant therapies included hydrochlorothiazide, levothyroxine sodium and simvastatin. On 09-JUL-2015, the patient noticed a large, red, warm, swollen area at her injection site. The patient went to the pharmacy the previous night to show the injection site adverse experiences to the pharmacist. The pharmacist stated that it looked like she developed a rash. He described the effected area's size as most of her deltoid area and it was pretty large. The patient had not notified her primary healthcare provider. There was no treatment rendered for the events. The outcome of the events were reported as not recovered/not resolved. The patient sought medical attention. Additional information has been requested.
Systemic: Fainting / Unresponsive-Medium, Systemic: Vomiting-Medium, Additional Details: About 3 minutes aftere receiving immunization, the patient fainted. She was unresponsive for about 5 seconds. We called 911. She vomited.
Information has been received from a health professional concerning a 14 year old female with no pre-existing allergies or medical condition or illness at time of vaccination who on 11-JUN-2012 at 15:45 PM was vaccinated with the first dose of GARDASIL (lot#672834/0131AE) into her left arm. There was no concomitant medication. On 11-JUN-2012 at 15:45 PM, the patient experienced dizzy, lightheaded and pale in color. The patient lay down, and elevated legs and head. Ice pack was applied to back of neck. No labs/diagnostics studies were performed. On 11-JUN-2012, the patient recovered from the events. This is one of several reports received from the same source. Additional information has been requested.
Fainting about 2 minutes after vaccine administration, pale, nystagmus. EMS contacted and patient checked out. Patient was allowed to go home with a driver.
Tired; Fatigued; This spontaneous case was reported by a patient and describes the occurrence of FATIGUE (Tired) and FATIGUE (Fatigued) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced FATIGUE (Tired) and FATIGUE (Fatigued). At the time of the report, FATIGUE (Tired) and FATIGUE (Fatigued) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported.  Treatment medications was not provided by the reporter
I developed headache, chills , 99.3 temperature, very tired with pain all over my joints particularly my back , shoulders, right arm at the site of the inyection and these symptoms lasted for 24 hrs . I feel fine and normal after one day of feeling these symptoms.
She wanted to know if the dose needed to be repeated; No additional AE reported; PROQUAD dose had been administered intramuscularly instead of subcutaneously; This spontaneous report was received from a physician refers to a 4 year old patient of unknown gender. The patient's concurrent conditions, medical history and concomitant therapies were not provided.  On 21-APR-2021, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD), 0.5 milliliter, lot# reported as "T033664", expired dose of 31-MAR-2022 had been administered intramuscularly instead of subcutaneously. She wanted to know if the dose needed to be repeated. No adverse event has been reported.
Inner ear pain (outer ear does not hurt) in my right ear. I started feeling this pain about 2 weeks after receiving the second dose of the Moderna COVID-19 vaccine (I received the second dose in my right arm). It presents itself about 3 times a day, nothing ignites or lessens the pain, it feels like a sharp stabbing pain, intensity 4/10 and lasts less than a second. Also presenting itchiness inside the ear canal.  Additionally, swollen and painful to the touch axillary lymph nodes. I noticed them about 2 weeks after receiving the first and second dose of the Moderna COVID-19 vaccine. They appeared on the same side of the vaccinated arm (i.e., left arm vaccinated, left axillary lymph nodes). They're sensitive to the touch, intensity 5/10. Did not take NSAIDs to reduce the pain (was afraid it might have been a breast lump, but ultrasound ruled it out and confirmed it was a swollen lymph node).
This is a spontaneous report from a contactable Nurse via Pfizer sales representative. A male patient of an unspecified age and ethnicity started to receive TRUMENBA, via an unspecified route of administration on an unspecified date at single dose. The patient medical history and concomitant medications were not reported. The patient experienced headache and general feeling of not being well day on an unspecified date with outcome of recovered by 2nd day post dose. No follow up attempts possible. No further information expected.
I had fever, cough, headache, SOB, low pulsus ox, and loss of smell. These symptoms lasted for about 10 days but the cough and loss of smell are ongoing. On Jan 4th, I tested positive for COVID-19. I was put in the hospital for 5 days. They did blood work, normal result. They also did x-ray, showed that I had pneumonia.
This description was reported to this writer. A few minutes after receiving the vaccine and sitting in the observation area, the patient's father told the nurse that his son was feeling lightheaded, was sweating and appeared pale. EMTs were notified and approached the patient. The patient was laid onto the ground and his legs were elevated. EMTs did an assessment and vital signs. Reported that the patient was hypotensive. Dad stated that his son had not eaten anything yet today. He was then given juice and a small candy bar which he ate. Patient was soon transferred to a wheelchair and taken to a nearby cot to lay down again. Dad stated this son does not have any allergies. Dad remained at son's side until released to go home by EMS. Patient ambulated unassisted toward the car.
The patient began experiencing a fever of 102.7, body aches/back pain, fatigue, and headaches the next morning after receiving the vaccine. She denies any respiratory symptoms. She tested positive for COVID19 on 12-01-2020. She was advised to remain off duty for 3 days, which accounts for the time period that these adverse effects have been observed per CDC data. If symptoms worsen, she was instructed to please follow up with a physician and to quarantine according to CDC guidance.
Around 7pm on the 11/01/2021 I noticed that I had lost of strength in my left arm. Before I got home for work, I had already started to itch and around 11:20pm that night I woke my wife up to check my left side and I was all reddish with a rash and itchy. Everything on my left-hand side was itchy. My neck, my ear, around my eyes and everything. I went and seen my doctor, Dr. at 4:30om on Tuesday, 11/2/2021. My doctor prescribed Benadryl and told me to take two pills every 6 hours until I felt better. No test was run. Well, she only checked my A1C afterwards. The result came back as 7.5.
This case was reported by a consumer via interactive digital media and described the occurrence of brain damage in a male patient who received DTP (A or W not known) (DTP (A or W not known)) for prophylaxis. On an unknown date, the patient received DTP (A or W not known) at an unknown dose. On an unknown date, unknown after receiving DTP (A or W not known), the patient experienced brain damage (serious criteria GSK medically significant). On an unknown date, the outcome of the brain damage was unknown. It was unknown if the reporter considered the brain damage to be related to DTP (A or W not known). Additional details were provided as follows: This case was received via social media post contents by the patient's aunt. The patient's family had no issues in the past with the shot. The age at vaccination was not reported. The reporter stated that the patient was severely mentally brain damaged from the DPT vaccine. This case was linked with case US2018GSK219958, reported by the same reporter.
UNSPECIFIED INFLAMMATION IN ALL MUSCLES LIKE ALL OF A SUDDEN MUSCLES DID NOT MOVE; This spontaneous report received from a consumer concerned a 59 year old male. The patient's height, and weight were not reported. The patient's past medical history included covid-19 infection. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21, and expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 01-DEC-2020, Laboratory data included: COVID-19 PCR test (NR: not provided) Positive. On 13-MAY-2021, the subject experienced unspecified inflammation from all of the muscles and muscles did not move all of a sudden. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from unspecified inflammation from all of the muscles and muscles did not move all of a sudden. This report was non-serious. This report was associated with product quality complaint: 90000182565 The suspected product quality complaint has been confirmed to be void: y (did not meet pqc criteria) based on the PQC evaluation/investigation performed.
I20.8 STABLE ANGINA 1/30/2023 SYNCOPE
ACT HIB vaccine was given to Patient and the diluent was ex[pired 03/07/2022But the vaccine itself was not it expires on 05/20/2022, Date on box was 03/07/22.  We called the patient and she will get another vaccine at a later time.
5x5 cm erythema/induration not painful.  Use ibuprofen & heat.